🚀 BREAKING NEWS: Given observed improvements in recognition, time to treatment and sepsis mortality realized through utilizing IntelliSep, patients across Louisiana and Mississippi will now have access to the test as we expand within the Franciscan Missionaries of Our Lady Health System’s unmatched network of world-class facilities. Cytovale is proud to partner with this leading health innovator to ensure that more patients receive the best sepsis care in the ED as possible. The test will now be available at the following FMOLHS facilities: 🔺 Our Lady of The Lake Regional Medical Center, LA 🔺 Our Lady of Lourdes Regional Medical Center, LA 🔺 St. Dominic’s Hospital, MS 🔺 St. Francis Medical Center, LA #Expansion #SepsisTest #EmergencyMedicine
Cytovale
Biotechnology Research
San Francisco, CA 12,464 followers
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
About us
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH
- Website
-
https://cytovale.com
External link for Cytovale
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Francisco, CA
- Type
- Privately Held
- Founded
- 2013
- Specialties
- medical device
Locations
-
Primary
150 Executive Park Blvd
San Francisco, CA 94134, US
Employees at Cytovale
-
Lindy Morris Fishburne
Managing Partner, Breakout Ventures
-
Angela Williams
Director, People & Culture, MA Organizational Leadership- Cytovale
-
Shaun Walsh
Seeing SEPSIS for the FIRST time
-
Bob Holliday, MBA
Global Learning & Development Executive | Talent Management | Leadership Development | Veteran | Change Management | Published Author | Strategic…
Updates
-
What if you could confidently rule-out sepsis for patients who present to your emergency room? A peer-reviewed analysis involving 1000+ adult ED patients with signs or suspicion of infection demonstrated that IntelliSep has a 98% NPV for sepsis—which may allow care teams to rule-out sepsis and explore alternative diagnoses in low-risk patients. Access the Academic Emergency Medicine article here to learn more: https://lnkd.in/gsevVKfD #EMResearch #EmergencyCare #SepsisManagement
-
Don’t miss this oral presentation on “Evaluation of a cellular host response test for risk stratifying patients presenting to the ED with signs or suspicion of urinary tract infection” at #ACEP24. Date: Oct. 1, 2024 Time: 12:00 pm PT Location: Research Forum Exhibit Hall- Room 4, Mandalay Bay Convention Center Register for ACEP24 today: https://www.acep.org/sa #InfectiousDiseases #ClinicalMicrobiology #EmergencyMedicine #UrinaryInfection
-
Join us at #ACEP24 for a Lunch and Learn session on how host response technology and the IntelliSep sepsis test can transform your ED triage. Hear from clinical leaders at major U.S. hospitals as they discuss the urgent need for improved sepsis diagnostics in the Emergency Department and how the IntelliSep test is enhancing patient-centric care. Date: September 29, 2024 Time: 11:30 am PT Location: Exhibit Hall, Mandalay Bay Convention Center Register for ACEP24 here: https://www.acep.org/sa #SepsisDetection #EmergencyMedicine #CriticalCare
-
Join Now: https://tab.so/d97fd57d The Cytovale webinar on “Saving Lives with Early Sepsis Detection - One Hospital’s Experience with IntelliSep” is now live! Join us. #Webinar #SepsisDetection
Join this week’s sponsored webinar with Cytovale to learn how IntelliSep is changing the way patients are triaged in the ED and leading to faster, more accurate sepsis detection. The conversation will feature leaders from Our Lady of the Lake Regional Medical Center in Louisiana as they share more about the impact of this novel technology on their patients. Register for free at https://lnkd.in/g6ACPQXB.
-
🚨Breaking News: Cytovale today announced that the Froedtert & the Medical College of Wisconsin Health Network is now screening patients with IntelliSep®, piloting the test at its flagship hospital, Froedtert Hospital in Milwaukee. IntelliSep is the first FDA-cleared rapid diagnostic test for the early detection of sepsis in an emergency department (ED) setting. Froedtert Hospital is the first in Wisconsin and in the Midwest to offer this life-saving technology. Nathan Ledeboer, PhD, Chief of Clinical Pathology at MCW and Associate Chief Medical Laboratory Officer for the Froedtert & MCW Health Network, shared, “This is the first blood test our clinicians have ever had in their toolbox that provides valuable insight into a patient’s immune system to detect sepsis earlier and make more informed treatment decisions.” Learn more: https://lnkd.in/g3h_zF59 #Milestone #SepsisTest
-
This is your reminder to sign up for the Cytovale webinar being held tomorrow! You will hear from leaders at Our Lady of the Lake Regional Medical Center regarding the impact that the IntelliSep sepsis test has had on their patients, day-to-day processes, and their overall organization. The webinar will be followed by a Q&A session with the team. Date: 21st August 2024 Time: 11am-12 pm PDT Register for the webinar here: https://tab.so/d97fd57d #SepsisAlliance #Webinar #EmergencyNurse #EmergencyMedicine
-
Already registered for #EN24, but can’t wait to learn more about the ~8-minute IntelliSep sepsis test? You don’t have to! Visit our Emergency Nursing 2024 Virtual booth and chat with our team right away or even set up 1:1 meetings: https://lnkd.in/gu-sqYaG #EmergencyNursing #SepsisCoordinators #EmergencyMedicine
-
Attention all #EmergencyPhysicians! Will you be at #ACEP24 this year in the bright city of Las Vegas, NV? Visit Cytovale at Booth# 1611 and discover how the FDA-cleared ~8-minute IntelliSep sepsis test could be a game-changer for your Emergency Department. Register for ACEP24 here: https://www.acep.org/sa #EmergencyMedicine #CriticalCare #Sepsis
-
🚨 Visit Us at Emergency Nursing 2024! 🚨 Cytovale is excited to be exhibiting at the Emergency Nursing 2024 Conference in Las Vegas, NV! Join us at Booth# 308 to discover how IntelliSep is transforming sepsis detection in the Emergency Department. Recent data from one hospital has shown that since their adoption of IntelliSep, the facility has reduced sepsis mortality by 20% in addition to: • 1800 fewer blood cultures post-IntelliSep implementation compared to a year ago. • 9 days of nurse staffing time saved. • ~2-day reduction in Length of Stay for ICU patients. Our team will be available to answer your questions and discuss how IntelliSep may help enhance patient care in your facility. 👉 Register for #EN24 here: https://lnkd.in/ejc3NdgF Data from one hospital: https://lnkd.in/emksAJqK #SepsisCoordinators #EmergencyNursing